ST. LOUIS, Sept. 30, 2024 /PRNewswire/ — Verde Resources, Inc (OTCQB: VRDR) is excited to announce a major achievement: the successful implementation of its innovative test section on the National Center for Asphalt Technology (NCAT) Test Track. This milestone represents the first ever…
Month: September 2024
ST. LOUIS, Sept. 30, 2024 /PRNewswire/ — Verde Resources, Inc (OTCQB: VRDR) is excited to announce a major achievement: the successful implementation of its innovative test section on the National Center for Asphalt Technology (NCAT) Test Track. This milestone represents the first ever…
PHU QUOC, Vietnam, Sept. 30, 2024 /PRNewswire/ — Recently named one of the Top 5 Best Luxury Romantic Beach Resorts in Vietnam 2024 by Luxury Lifestyle Award, Salinda Resort Phu Quoc Island is more than just a tropical escape – it’s a romantic sanctuary. Known for its intimate…
PHU QUOC, Vietnam, Sept. 30, 2024 /PRNewswire/ — Recently named one of the Top 5 Best Luxury Romantic Beach Resorts in Vietnam 2024 by Luxury Lifestyle Award, Salinda Resort Phu Quoc Island is more than just a tropical escape – it’s a romantic sanctuary. Known for its intimate…
Valour’s First Listed Product on LSE: Valour Digital Securities Limited marks a significant milestone with the launch of its first asset-backed Ethereum Physical Staking exchange traded product (ETP) also known as exchange traded note (ETN) on the London Stock Exchange, offering…
Valour’s First Listed Product on LSE: Valour Digital Securities Limited marks a significant milestone with the launch of its first asset-backed Ethereum Physical Staking exchange traded product (ETP) also known as exchange traded note (ETN) on the London Stock Exchange, offering…
Biohaven initiated a pivotal Phase 2 trial evaluating BHV-2100 in the acute treatment of migraine BHV-2100 is a potential first-in-class, potent, orally administered Transient Receptor Potential Melastatin-3 (TRPM3) antagonist— a novel, highly selective, and non-opioid investigational…
Biohaven initiated a pivotal Phase 2 trial evaluating BHV-2100 in the acute treatment of migraine BHV-2100 is a potential first-in-class, potent, orally administered Transient Receptor Potential Melastatin-3 (TRPM3) antagonist— a novel, highly selective, and non-opioid investigational…
ANCHORAGE, AK, Sept. 30, 2024 /PRNewswire/ – U.S. GoldMining Inc. (NASDAQ: USGO) (“U.S. GoldMining” or the “Company”) is pleased to announce initial assay results from the first two diamond drill holes completed of its 2024 drilling program at the Whistler Gold-Copper Project (the…
ANCHORAGE, AK, Sept. 30, 2024 /PRNewswire/ – U.S. GoldMining Inc. (NASDAQ: USGO) (“U.S. GoldMining” or the “Company”) is pleased to announce initial assay results from the first two diamond drill holes completed of its 2024 drilling program at the Whistler Gold-Copper Project (the…